|
Mar 26
|
UPDATE 1-China to speed up 'new productive forces', vice president says
|
|
Mar 25
|
Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know
|
|
Mar 25
|
31 European Countries That Offer Citizenship by Descent
|
|
Mar 25
|
German industry sceptical of China's vow to treat foreign firms equally
|
|
Mar 25
|
Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
|
|
Mar 25
|
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
|
|
Mar 22
|
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
|
|
Mar 22
|
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
|
|
Mar 22
|
Ionis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?
|
|
Mar 21
|
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
|
|
Mar 21
|
UPDATE 2-Merck combination treatment for lung cancer fails late-stage study
|
|
Mar 20
|
UPDATE 1-GSK to cap out-of-pocket inhaler costs in US
|
|
Mar 20
|
15 Countries with the Highest Life Expectancy in Africa
|
|
Mar 20
|
3 Stagnating Blue-Chip Stocks Ready to Awaken and Soar
|
|
Mar 20
|
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
|
|
Mar 20
|
AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
|
|
Mar 20
|
PRESS DIGEST-British Business - March 20
|
|
Mar 19
|
Astrazeneca (AZN) Rises Yet Lags Behind Market: Some Facts Worth Knowing
|
|
Mar 19
|
These Stocks Moved the Most Today: Nvidia, AMD, Super Micro, Fusion Pharmaceuticals, Nordstrom, International Paper, Tesla, and More
|
|
Mar 19
|
Fusion Rockets 97%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover
|